Company intelligence / Profile preview

CYFR

Muscat, Oman

Ownership: Private
Development stage: Other

Overview

Cyfr Capital appears to be an active venture capital firm rather than a life sciences, biotech, pharma, or healthcare operating company. Publicly available sources describe it as an investment firm focused on backing startups and providing growth support, with an online presence centered on investment activities and regional networks rather than therapeutic R&D, products, or clinical development. Based on the available evidence, "CYFR" does not map cleanly to a biotech or healthcare company exact match. Accordingly, no drug pipeline, modalities, targets, or clinical-stage programs could be substantiated.

Industry: Investors

Beyond the preview

Go deeper on CYFR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CYFR.

Explore the full profile